Pfizer and BioNTech announced Tuesday that they asked U.S. regulators to authorize a second Covid-19 vaccine booster for people 65 and older. If the Food and Drug Administration grants authorization, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results